Lu Han - Profile and Investment Details

Investor Profile

Lu Han is a Venture Capital, Private Equity Firm based in Vancouver, British Columbia, Canada with a diverse investment portfolio that includes companies such as Cardiac Dimensions, Exact Imaging, Notch Therapeutics, Social Change Rewards, Deka Biosciences, Inc, OsteoQC, OsteoQC IncEdesa Biotech, GenEp, Aurinia Pharmaceuticals, KalGene Pharmaceuticals, AmacaThera, Opsens, Thrasos, Thryv Therapeutics Inc., Iterion Therapeutics, Celtaxsys, Angelini Lumira Biosciences Fund, Vendorlink.ca, Bardy Diagnostics, Rare Neurodegenerative Disorder co (in stealth mode), Pediapharm, Osteopathy Quebec, IMV, XyloCor Therapeutics, Corvia Medical, Spinal Kinetics, Engage Therapeutics, Forbius, Cyrano Therapeutics, Endotronix, First Aid Shot Therapy, Usystems, Zymeworks, G1 Therapeutics, Vascular Pharmaceuticals, HistoSonics, Alpha-9 Oncology, HistoSonics, Inc., BAROnova, Gladius Pharmaceuticals, Bright Angel Therapeutics, Nocion Therapeutics, Inc., Cadence Neuroscience Inc., Antios Therapeutics, Satsuma Pharmaceuticals, IMV Inc, KisoJi Biotechnology, Argos Therapeutics, enGene, . Over time, Lu Han has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Lu Han is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Women Founded, Biotechnology, Developer Tools, Medical, Therapeutics, Pharmaceuticals may find it worthwhile to explore potential connections with Lu Han, as their portfolio suggests a familiarity and interest in this area.

Understanding Lu Han’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.